Hope as tuberculosis vaccine trials enter final phase

Kenya: As the world celebrates the World Tuberculosis (TB) Day today, Kenya is among the countries conducting clinical trials on a vaccine for adults to counter the deadly disease.

The search for an effective vaccine to avoid development of the disease from latent to active TB has entered the final phase as Kenya Medical Research Institute (Kemri) and Aeras launch the clinical trial for M72 vaccine.